Stipple Bio, Inc. filed a Form D with the Securities and Exchange Commission on 2026-04-06.
Stipple Bio, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 6, 2026. The filing reports $65.13M sold. Its industry group is Biotechnology. It names Jeffrey Landau (Executive Officer, Director), Vineeta Agarwala (Director), Owen Hughes (Director) (SEC Form D, April 6, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Stipple Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-04-06 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Stipple Bio, Inc.
Free to see. No signup.
More on the people and the money behind Stipple Bio, Inc., from the filings we hold.
Biotechnology raises by companies based in Massachusetts, filed in April 2026, largest first.
Get an email when Stipple Bio, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Stipple Bio, Inc. raises, hires or launches. No email unless you switch it on.
Watch Stipple Bio, Inc. →Get the full cited report on Stipple Bio, Inc.
What the filing shows about Stipple Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Stipple Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Stipple Bio, Inc.'s address as 238 Main Street, Cambridge, MA 02142.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Stipple Bio, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Stipple Bio, Inc. is a registered filer with the SEC (CIK 1932776) and has filed since 2024-12-20. 2 filings are on record, the latest on 2026-04-06.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Stipple Bio, Inc.'s Form D of 2026-04-06 names Jeffrey Landau, Vineeta Agarwala, Owen Hughes and 4 more as its officers, directors or promoters.
Its new offerings report $74.61M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 771 filings in Biotechnology, totalled by week. The dot is this raise, $65.13M, on the same scale — one filing against the whole group's total, so it sits low by construction.
No amount other than ordinary course employment compensation is being paid to officers and directors.
Jeffrey Landau is named as Executive Officer and Director on the Form D that Stipple Bio, Inc. filed with the SEC on 6 April 2026, one of 7 people that filing names.
Vineeta Agarwala is named as Director on the Form D that Stipple Bio, Inc. filed with the SEC on 6 April 2026, one of 7 people that filing names.
Owen Hughes is named as Director on the Form D that Stipple Bio, Inc. filed with the SEC on 6 April 2026, one of 7 people that filing names.
Greg Verdine is named as Director on the Form D that Stipple Bio, Inc. filed with the SEC on 6 April 2026, one of 7 people that filing names.
Aaron Ring is named as Director on the Form D that Stipple Bio, Inc. filed with the SEC on 6 April 2026, one of 7 people that filing names.
Derek DiRocco is named as Director on the Form D that Stipple Bio, Inc. filed with the SEC on 6 April 2026, one of 7 people that filing names.
Thilo Schroeder is named as Director on the Form D that Stipple Bio, Inc. filed with the SEC on 6 April 2026, one of 7 people that filing names.
7 people named on the filing — 1 holding an executive role and 6 as directors only.
Named as of the 2026-04-06 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Stipple Bio, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Stipple Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Stipple Bio, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Stipple Bio, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Stipple Bio, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Stipple Bio, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/stipple-bio-inc-form-d-26000002